Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Neuroblastoma 2Sarcoma 1Retinoblastoma 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Lymphoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Filgrastim 8Granulocyte Colony-Stimulating Factor 7Thiotepa 6Etoposide 5Carboplatin 5Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Busulfan 4Melphalan 3Ifosfamide 3Topotecan 2Mesna 2sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1etoposide phosphate 1cixutumumab 1becatecarin 1alvocidib 1Vincristine 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Temozolomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Retinoblastoma × becatecarin × CNS × Clear all
NCT00006102 2013-02-05

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
200 enrolled
CNSLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Neuroblastoma, Oligodendroglioma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡